Find Clinical Trials

Search thousands of clinical trials by condition, location, and eligibility criteria

0
Total Trials
0
Trials Recruiting
0
Conditions Covered
0
Locations Worldwide
0
Sponsors
Clinical trial guides

Browse trials by condition

View all guides

Browse by location

Showing 12 of 4196 trials
Conditions Head and Neck Carcinoma
Phase NA
Enrollment 40
Locations 1 sites
Compensation Not reported — ask the study team
Data Updated 2026-11-05
Study Details Design, interventions, and primary outcomes

About This Study

This clinical trial tests how well a three-dimensional (3D) mindfulness virtual reality (VR) versus (vs) two-dimensional (2D) non-immersive interventions works in improving depression, anxiety, pain, and/or stress in patients with head and neck cancer (HNC) undergoing radiation or chemoradiation (C/RT), and their caregivers. HNC patients undergoing C/RT can experience higher levels of depression, anxiety, distress and pain that negatively impact their quality of life. VR allows for a realistic experience and works as an effective distraction tool from the state of pain or anxiety without use of drugs and with minimal associated risk to patients. VR has been shown to help reduce symptoms of depression, anxiety and pain in non-cancer patients, however there is limited evidence of how well VR use works in cancer patients, especially in patients undergoing C/RT for HNC. Caregivers of these patients also experience high levels of anxiety and distress. Using VR interventions may improve depression, anxiety, pain and/or stress in patients with HNC undergoing C/RT and their caregivers.

Design

Study type: Interventional Phases: Allocation: Randomized Intervention model: Parallel Primary purpose: Supportive Care Masking/blinding: None

Interventions / Regimen

  • Other: Interview — Ancillary studies
  • Other: Medical Device Usage and Evaluation — Wear a Fitbit
  • Other: Questionnaire Administration — Ancillary studies
  • Other: Virtual Technology Intervention — Receive 3D mindfulness VR headset
  • Other: Virtual Technology Intervention — Receive 2D non-immersive VR headset

Primary Outcomes

  • Recruitment rate (Feasibility) (Up to 11 weeks)
  • Retention rate (Feasibility) (Up to 11 weeks)
  • Adherence to three-dimensional (3D) mindfulness virtual reality (VR) intervention (Feasibility) (Up to 11 weeks)
  • Completion of electronic patient reported outcomes (ePRO) (Feasibility) (Up to 11 weeks)
  • Acceptability of 3D mindfulness VR intervention (Up to 11 weeks)
Interested in this trial?
Contact the study team directly or view the official listing
Study Information
Type: INTERVENTIONAL
Phase: NA
Status: Recruiting
Start Date: 2025-06-25
Completion: 2027-11-09
Eligibility
Age: 18 Years and older
Sex: ALL
Volunteers: true
Enrollment: 40 (ESTIMATED)
Sponsor & Investigators
Lead Sponsor: City of Hope Medical Center
Collaborators: National Cancer Institute (NCI)
Principal Investigators:
  • Krupal Patel (PRINCIPAL_INVESTIGATOR) - City of Hope Medical Center
Contact Information
Study Contact:
Krupal Patel
626-256-4673
kruppatel@coh.org
City of Hope Medical Center
Krupal Patel
City of Hope Medical Center
Interventions
  • Other: Interview — Ancillary studies
  • Other: Medical Device Usage and Evaluation — Wear a Fitbit
  • Other: Questionnaire Administration — Ancillary studies
  • Other: Virtual Technology Intervention — Receive 3D mindfulness VR headset
  • Other: Virtual Technology Intervention — Receive 2D non-immersive VR headset
Study Locations (1 sites)
City of Hope Medical Center, Duarte, California 91010 United States
Eligibility Criteria
Inclusion Criteria: * PATIENTS: Documented informed consent of the participant and/or legally authorized representative * Assent, when appropriate, will be obtained per institutional guidelines * PATIENTS: ≥ 18 years * PATIENTS: Self-reported normal or corrected to normal vision and hearing * PATIENTS: Ambulatory (permitted to use walking aids such as cane or crutch) * PATIENTS: Ability to read and understand English for questionnaires * PATIENTS: Scheduled to undergo C/RT for their HNC * CAREGIVERS: Documented informed consent of the participant and/or legally authorized representative * Assent, when appropriate, will be obtained per institutional guidelines * CAREGIVERS: ≥ 18 years * CAREGIVERS: Self-reported normal or corrected to normal vision and hearing * CAREGIVERS: Ability to read and understand English for questionnaires * CAREGIVERS: A care giver identified by the patient and defined as a person who knows the patient well and is involved in the patient's medical care Exclusion Criteria: * PATIENTS: An employee who is under the direct/ indirect supervision of the principal investigator (PI)/ a co-investigator/ the study manager * PATIENTS: A direct study team member * PATIENTS: Inability to complete the surveys * PATIENTS: Serious mental illness * PATIENTS: Previous head and neck cancer treatment * PATIENTS: History of any psychiatric disease treatment with anti-depressants, substance abuse, post-traumatic stress disorder (PTSD), chronic pain (\> 3 months) * PATIENTS: Cancer in or around the eyes or ears; visual, hearing or cognitive impairment * CAREGIVERS: An employee who is under the direct/ indirect supervision of the PI/ a co-investigator/ the study manager * CAREGIVERS: A direct study team member * CAREGIVERS: Inability to complete the surveys * CAREGIVERS: Serious mental illness * CAREGIVERS: History of any psychiatric disease treatment with anti-depressants, substance abuse, PTSD
Conditions Depression, Anxiety
Phase NA
Enrollment 84
Locations 2 sites
Compensation Not reported — ask the study team
Data Updated 2026-11-05
Study Details Design, interventions, and primary outcomes

About This Study

Depressive symptoms are commonly observed in the general population. Individuals with subclinical forms of depression (e.g., not meet the criteria to major depression disorder) are at increased risk of mortality than the general population which is partially explained by the higher incidence of cardiovascular diseases. Currently, the effectiveness of the frontline treatment for depression is not consensual. Further, it also may be expensive for individuals with mild to moderate depression. Sedentary behavior is an independent risk factor for cardiometabolic diseases and mental disorders. However, recent evidence suggests that not all types of sedentary behavior are equally detrimental. For instance, mentally passive sedentary behavior (e.g., watching TV) appear to be detrimental for health outcomes whereas mentally active sedentary behavior (e.g., desk-based office work) appear to offer health benefits. However, more studies are required to determine the magnitude of association between distinct types of sedentary behaviors (e.g., watching TV, listening to music, talking while sitting, sitting around and doing nothing special) with depressive symptoms as well as randomized clinical trials investigating potential benefits of interventions to replace mentally-passive sedentary behaviors with mentally active sedentary behaviors, light physical activity or moderate-to-vigorous activity in individuals with mild to moderate depression. Therefore, the aim of this proposal is to investigate the influence of mentally passive sedentary behavior (i.e., watching TV, listening to music, talking while sitting, sitting around, and doing nothing special) on depressive symptoms. This is a randomized clinical trial. Participants with mild to severe depressive symptoms will be randomly assigned (1:1) into either INTERVENTION or CONTROL group, using a computer-generated randomization code. Depressive symptoms, quality of life, physical activity, sedentary behavior, body composition, and functionality will be assessed at baseline (PRE) and 4 (POST) months after the experimental period. The INTERVENTION group will participate in a 4-month goal-setting intervention aimed to replace mentally passive sedentary behaviors with mentally active sedentary behaviors, light physical activity, or moderate-to-vigorous activity while CONTROL group will receive general instructions related to WHO guidelines for physical activity.

Design

Study type: Interventional Phases: Allocation: Randomized Intervention model: Parallel Primary purpose: Treatment Masking/blinding: Single

Interventions / Regimen

  • Behavioral: Physical activity intervention — The INTERVENTION group will participate in a 4-month goal-setting intervention aimed to replace mentally passive sedentary behaviors with mentally active sedentary behaviors, light physical activity, or moderate-to-vigorous activity.
  • Behavioral: Standard of care — The CONTROL group also will participate of 4 face-to-face individual sessions during the experimental period, lasting \~15-30 minutes, however they will receive general instructions related to WHO guidelines for physical activity

Primary Outcomes

  • Depressive Symptoms (Baseline (Pre-intervention) and 16 weeks (Post-intervention))
Interested in this trial?
Contact the study team directly or view the official listing
Study Information
Type: INTERVENTIONAL
Phase: NA
Status: Recruiting
Start Date: 2025-06-01
Completion: 2026-07-01
Eligibility
Age: 18 Years and older
Sex: ALL
Volunteers: false
Enrollment: 84 (ESTIMATED)
Sponsor & Investigators
Lead Sponsor: University of Sao Paulo General Hospital
Contact Information
Study Contact:
Saulo Gil
5511970273059
ssgil@prof.unisa.br
University of Santo Amaro
Saulo Gil
University of Santo Amaro
Saulo Gil
+551197027-3059
ssgil@prof.unisa.br
University Santo Amaro
Interventions
  • Behavioral: Physical activity intervention — The INTERVENTION group will participate in a 4-month goal-setting intervention aimed to replace mentally passive sedentary behaviors with mentally active sedentary behaviors, light physical activity, or moderate-to-vigorous activity.
  • Behavioral: Standard of care — The CONTROL group also will participate of 4 face-to-face individual sessions during the experimental period, lasting \~15-30 minutes, however they will receive general instructions related to WHO guidelines for physical activity
Study Locations (2 sites)
University of Santo Amaro, São Paulo, SO 04829-300 Brazil
University Santo Amaro, São Paulo, São Paulo 04829-300 Brazil
Eligibility Criteria
Inclusion Criteria: * individuals aged over 17 years; * mild to severe depressive symptoms. Exclusion Criteria: * cancer in the past 5 years; * inability to perform the physical tests; * prior diagnosis of muscle degenerative disease (e.g., myopathies, amyotrophic lateral sclerosis);
Conditions Major Depressive Disorder With Excessive...
Phase PHASE3
Enrollment 508
Locations 40 sites
Compensation Not reported — ask the study team
Data Updated 2026-11-05
Study Details Design, interventions, and primary outcomes

About This Study

CLARITY (Clinical Assessment of Response in the Treatment of Depression with Daytime Sleepiness Using Solriamfetol) is a Phase 3, double-blind, placebo-controlled, multicenter randomized withdrawal trial in patients with major depressive disorder (MDD) with excessive daytime sleepiness (EDS) symptoms consisting of an open-label solriamfetol treatment period and a randomized, double-blind treatment period.

Design

Study type: Interventional Phases: Phase3 Allocation: Randomized Intervention model: Parallel Primary purpose: Treatment Masking/blinding: Double

Interventions / Regimen

  • Drug: Solriamfetol 150 MG — Solriamfetol tablets, taken once daily
  • Drug: Placebo — Placebo tablets, taken once daily

Primary Outcomes

  • Time from randomization to relapse of depressive symptoms (Up to 24 weeks.)
Interested in this trial?
Contact the study team directly or view the official listing
Study Information
Type: INTERVENTIONAL
Phase: PHASE3
Status: Recruiting
Start Date: 2026-02-23
Completion: 2028-12
Eligibility
Age: 18 Years – 65 Years
Sex: ALL
Volunteers: false
Enrollment: 508 (ESTIMATED)
Sponsor & Investigators
Lead Sponsor: Axsome Therapeutics, Inc.
Contact Information
Study Contact:
Study Director
2123325061
sol-mdd-302@axsome.com
Interventions
  • Drug: Solriamfetol 150 MG — Solriamfetol tablets, taken once daily
  • Drug: Placebo — Placebo tablets, taken once daily
Study Locations (40 sites)
Clinical Research Site, Tucson, Arizona 85704 United States
Clinical Research Site, Bellflower, California 90706 United States
Clinical Research Site, Chino, California 91710 United States
Clinical Research Site, Glendale, California 91206 United States
Clinical Research Site, Imperial, California 92251 United States
Clinical Research Site, Los Angeles, California 90015 United States
Clinical Research Site, Oceanside, California 92056 United States
Clinical Research Site, Redlands, California 92374 United States
Clinical Research Site, San Diego, California 92123 United States
Clinical Research Site, Sherman Oaks, California 91403 United States
Eligibility Criteria
Inclusion Criteria: * Currently meets the DSM-5 criteria for MDD without psychotic features, based on the SCID-5-CT * Excessive daytime sleepiness symptoms * Able to comply with study procedures * Male or female, aged 18 to 65 years inclusive Exclusion Criteria: * Any clinically significant medical (e.g., OSA, narcolepsy), behavioral, or psychiatric disorder, other than MDD with EDS symptoms * Unable to comply with study procedures * Medically inappropriate for study participation in the opinion of the investigator
Conditions Well-Being, Psychological, Loneliness
Phase NA
Enrollment 148
Locations 1 sites
Compensation Not reported — ask the study team
Data Updated 2026-11-05
Study Details Design, interventions, and primary outcomes

About This Study

The goal of this trial is to learn if the Groups 4 Health (G4H) intervention is effective in supporting student well-being at the University of Helsinki. It will also learn about the factors that may influence the efficacy of the intervention (such as facilitators characteristics, stress physiology and changes in gene expression). The main questions it aims to answer are: 1. Is the G4H intervention effective and cost-effective in supporting student well-being? 2. To what extent participants' physiological, hormonal, or molecular characteristics mediate the therapeutic effect of the G4H 3. To what extent participants' genotype moderates the effect of the G4H 4. To what extent facilitators' characteristics mediate or moderate the effect of the G4H Data is collected from both the intervention participants and the facilitators. The G4H facilitators will: * Facilitate the G4H intervention. * Fill in questionnaires and provide physiological and molecular measurements before, during, and after the G4H intervention. The G4H participants will: * Participate in the G4H intervention. * Fill in questionnaires and provide physiological, hormonal and molecular measurements before, during, and after the G4H intervention.

Design

Study type: Interventional Phases: Allocation: Randomized Intervention model: Single Group Primary purpose: Treatment Masking/blinding: None

Interventions / Regimen

  • Behavioral: Groups 4 health — Groups 4 Health (G4H) at the University of Helsinki is a manualized group intervention for the students that focuses on social connectedness and aims at improving general health and life satisfaction. G4H groups are facilitated by two psychology master's students (or licensed psychologists) carefully trained for the intervention and mentored by experienced clinical psychologists. G4H consists of five 90 minutes sessions that aim to give participants the knowledge and skills they need to effectively manage their social group memberships and identities. Each session contains exercises and discussions described in the G4H workbook that target different aspects of group life identified within the social identity model of identity change and put the Social Identity Approach to Health -model to practice. Students earn 2 European Credit Transfer and Accumulation System (ECTS) credits for completing the intervention.

Primary Outcomes

  • Loneliness (1) Before the intervention, 2) During the intervention (week 3), 3) immediately after the intervention, 4) one month follow-up, 5) three months follow-up, 6) 12 months follow-up)
  • Depression (1) Before the intervention, 2) immediately after the intervention 3) one month follow-up, 4) three months follow-up, 5) 12-months follow-up)
  • Active group memberships (1) Before the intervention, 2) During the intervention (week 3), 3) immediately after the intervention, 4) one month follow-up, 5) three months follow-up, 6) 12-months follow-up)
  • Mental well-being (1) Before the intervention, 2) immediately after the intervention 3) one month follow-up, 4) three months follow-up, 5) 12-months follow-up)
  • General well-being (1) Before the intervention, 2) immediately after the intervention 3) one month follow-up, 4) three months follow-up, 5) 12-months follow-up)
  • Anxiety (1) Before the intervention, 2) immediately after the intervention 3) one month follow-up, 4) three months follow-up, 5) 12-months follow-up)
  • Social anxiety (1) Before the intervention, 2) immediately after the intervention 3) one month follow-up, 4) three months follow-up, 5) 12-months follow-up)
Interested in this trial?
Contact the study team directly or view the official listing
Study Information
Type: INTERVENTIONAL
Phase: NA
Status: Recruiting
Start Date: 2025-09-12
Completion: 2028-12
Eligibility
Age: 18 Months and older
Sex: ALL
Volunteers: true
Enrollment: 148 (ESTIMATED)
Sponsor & Investigators
Lead Sponsor: University of Helsinki
Collaborators: Strategic Research Council, Finland, University of Eastern Finland, Finnish Institute for Health and Welfare, Finnish Cultural Foundation
Contact Information
Study Contact:
Jari Lahti, PhD
040 571 2297
jari.lahti@helsinki.fi
Jari Lahti, PhD
040 571 2297
jari.lahti@helsinki.fi
University of Helsinki
Interventions
  • Behavioral: Groups 4 health — Groups 4 Health (G4H) at the University of Helsinki is a manualized group intervention for the students that focuses on social connectedness and aims at improving general health and life satisfaction. G4H groups are facilitated by two psychology master's students (or licensed psychologists) carefully trained for the intervention and mentored by experienced clinical psychologists. G4H consists of five 90 minutes sessions that aim to give participants the knowledge and skills they need to effectively manage their social group memberships and identities. Each session contains exercises and discussions described in the G4H workbook that target different aspects of group life identified within the social identity model of identity change and put the Social Identity Approach to Health -model to practice. Students earn 2 European Credit Transfer and Accumulation System (ECTS) credits for completing the intervention.
Study Locations (1 sites)
University of Helsinki, Helsinki, Uusimaa 00014 Finland
Eligibility Criteria
Inclusion Criteria: * Adult (age 18 and above) * Student in the University of Helsinki, Finland * Able to speak/read Finnish, Swedish, or English Exclusion Criteria: * None
Conditions Perinatal Mental Health, Reproductive Be...
Phase Not Applicable
Enrollment 328
Locations 1 sites
Compensation Not reported — ask the study team
Data Updated 2026-11-05
Study Details Design, interventions, and primary outcomes

About This Study

The goal of this observational study is to learn how war affects reproductive decisions and perinatal mental health in Ukrainian women. The main questions it aims to answer are: (1) how are wartime stress and trauma related to women's decisions about pregnancy and childbirth?; (2) what mental health symptoms and psychological difficulties are experienced during the perinatal period under wartime conditions? (3) which demographic, obstetric, and psychological factors are linked to poorer mental health and childbirth experiences? Researchers will survey at least 300 women. Participants will: (1) complete questionnaires about their mental health and psychological well-being; (2) answer questions about their reproductive choices, pregnancy, and/or childbirth experiences; (3) report on the impact of war, social support, maternal care, and postpartum trauma; (4) provide demographic and obstetric information. The findings will be used to develop an evidence-based model of the factors influencing reproductive behavior and perinatal mental health during war.

Design

Study type: Observational Observational model: Cohort Time perspective: Prospective

Interventions / Regimen

  • Diagnostic Test: Psychological Assessment — A participant-completed questionnaire administered to eligible women and, where applicable, to partners included in the supplementary dyadic component. Question flow will be adapted through programmed routing logic so that participants are presented only with items relevant to their reproductive stage and experiences.
  • Diagnostic Test: Routine Clinical Data Collection — Clinical data abstracted from routine medical records, including maternal, obstetric, fetal, delivery, and neonatal indicators relevant to the study. Data collection will be limited to information available in routine care and recorded only with participant consent.

Primary Outcomes

  • World Health Organization - Five Well-Being Index (Baseline, 3 months, 6 months, and 12 months after enrolment.)
Interested in this trial?
Contact the study team directly or view the official listing
Study Information
Type: OBSERVATIONAL
Phase: Not Applicable
Status: Recruiting
Start Date: 2026-07-07
Completion: 2028-11
Eligibility
Age: 18 Years and older
Sex: ALL
Volunteers: true
Enrollment: 328 (ESTIMATED)
Sponsor & Investigators
Lead Sponsor: Taras Shevchenko National University of Kyiv
Contact Information
Study Contact:
Nazar Yatsenko, MSc
+380733700423
nazaryatsenko@knu.ua
Nazar Yatsenko, MSc
+380733700423
nazaryatsenko@knu.ua
Taras Shevchenko National University of Kyiv
Liudmyla Krupelnytska, DSc
Taras Shevchenko National University of Kyiv
Interventions
  • Diagnostic Test: Psychological Assessment — A participant-completed questionnaire administered to eligible women and, where applicable, to partners included in the supplementary dyadic component. Question flow will be adapted through programmed routing logic so that participants are presented only with items relevant to their reproductive stage and experiences.
  • Diagnostic Test: Routine Clinical Data Collection — Clinical data abstracted from routine medical records, including maternal, obstetric, fetal, delivery, and neonatal indicators relevant to the study. Data collection will be limited to information available in routine care and recorded only with participant consent.
Study Locations (1 sites)
Taras Shevchenko National University of Kyiv, Kyiv, Ukraine
Eligibility Criteria
Inclusion Criteria: * able and willing to provide informed consent; * aged 18 years or older. Exclusion Criteria: * younger than 18 years; * unable to provide informed consent; * do not have sufficient language proficiency to complete the study procedures; * at the time of recruitment, they have an acute medical or psychological condition that would make participation unsafe, inappropriate, or unduly burdensome (e.g., obstetric emergencies, immediate postoperative or critical care status, or severe acute distress requiring urgent clinical care); * participation or the handling of personal data could reasonably pose a risk to the safety of the participant or their family.
Conditions Depression, Post Traumatic Stress Disord...
Phase Not Applicable
Enrollment 30000
Locations 1 sites
Compensation Not reported — ask the study team
Data Updated 2026-11-05
Study Details Design, interventions, and primary outcomes

About This Study

While effective interventions for depression exist, their success rates are unsatisfactory and their provision is haphazard. The Canadian Depression Research and Intervention Network (CDRIN) Maritimes Depression Hub will improve the delivery of care and the quality of outcomes for youths, adults and seniors with depression across the Maritimes. The investigators will establish an integrated system of assessment, treatment, research and education related to depression with the active involvement of those with lived experience. The establishment of a patient registry is a key step that will facilitate evaluation and reform of current services, integration of patient choice and community resources into treatment programs, monitoring long-term outcomes, and development of more effective treatment approaches through research. The registry will facilitate research that will include validation of new diagnostic and outcome measurement tools, low-cost clinical trials and collaborative projects with national and international partners. Educational programs will involve training the next generation of researchers, those with lived experience, clinicians, and health system managers in critical appraisal and will facilitate their involvement in research. The registry, the proposed systematic measurement of outcomes and the broad dissemination of information and skills will improve the quality of research and of care as well as the experience of patients and their families. The need for a registry: It is increasingly recognized that major advances in the treatment of mental disorders will require large scale clinical research. Recently demonstrated ways of completing large-scale research with finite resources include the routine use of electronic health records (EHR), data linkage and randomized registry trial. Use of EHR is the most efficient way of rapidly obtaining large amounts of information. However, EHR cannot completely exclude confounding by indication and other unmeasured variables. Therefore, tests of treatment effects require experimental designs that cannot be replaced by routine health records data. The gold standard for testing the effects of treatment in an unbiased way is the randomized controlled trial (RCT), where measured and unmeasured confounders are balanced through the randomization process and any remaining confounding is due to chance alone. RCTs are valued as the highest level of evidence, but are costly and take significant time to be completed, partly because of the need to screen a large group of individuals to identify eligible participants. The most efficient unbiased test of interventions, new treatment modalities and novel ways of treatment delivery is a method that combines EHR use with the randomized controlled trial (RCT) methodology: the randomized registry trial (RRT). The RRT takes advantage of a registry of individuals with available information to identify a large number of individuals suitable for an RCT. The RRT…

Design

Study type: Observational Observational model: Cohort Time perspective: Prospective

Primary Outcomes

  • Status Assessment: General Functioning Youth (10 years)
  • Status Assessment: Role and Social Functioning in Adults (10 years)
  • Status Assessment: Work and Social Functioning (10 years)
  • Status Assessment: Work Productivity (10 years)
Interested in this trial?
Contact the study team directly or view the official listing
Study Information
Type: OBSERVATIONAL
Phase: Not Applicable
Status: Recruiting
Start Date: 2015-05
Completion: 2029-12-31
Eligibility
Age: Not reported
Sex: ALL
Volunteers: true
Enrollment: 30000 (ESTIMATED)
Sponsor & Investigators
Lead Sponsor: Nova Scotia Health Authority
Collaborators: IWK Health Centre, Nova Scotia Health Research Foundation, Dalhousie University
Principal Investigators:
  • Rudolf Uher, MD, PhD (PRINCIPAL_INVESTIGATOR) - Nova Scotia Health Authority
  • David J Pilon, PhD (STUDY_DIRECTOR) - Nova Scotia Health Authority
Contact Information
Study Contact:
Jessica Toombs, MSc
1-902-473-5313
jessica.toombs@nshealth.ca
Jessica Toombs, MSc
902-473-5313
jessica-toombs@nshealth.ca
Nova Scotia Health Authority
Rudolf Uher, MD, PhD
902-473-7209
uher@dal.ca
Nova Scotia Health Authority
Interventions
N/A
Study Locations (1 sites)
Nova Scotia Health Authority, Halifax, Nova Scotia B3H 2E2 Canada
Eligibility Criteria
Inclusion Criteria: * male or female * seeking or receiving help for mental health related problems in the maritime provinces of Canada * able to provide informed consent or have an appropriate substitute decision maker that can provide consent on their behalf. * English or French speaking Exclusion Criteria: * There are no exclusion criteria related to age, sex, or ethnicity. * Whilst the recruitment will be targeted to include individuals suffering with depression and other types of mental illness, no specific diagnosis is required for participation in the registry. * unable to provide informed consent or does not have an appropriate substitute decision maker that can provide consent on their behalf * does not speak English or French
Conditions Fibromyalgia, Psychological Trauma, Depr...
Phase NA
Enrollment 96
Locations 1 sites
Compensation Not reported — ask the study team
Data Updated 2026-11-05
Study Details Design, interventions, and primary outcomes

About This Study

Fibromyalgia (FM) is a generalized, widespread chronic pain disorder and has an estimated prevalence of 2%-4% in the general population. Current pharmacological and psychological interventions frequently produce limited benefits in FM patients. Due to FM's strong association with psychological trauma causing neurobiological alterations in stress response, a trauma-focused psychotherapy is an innovative alternative treatment option. Eye Movement Desensitization and Reprocessing (EMDR) has been recognized by the World Health Organization as a first-line therapeutic tool for post-traumatic stress disorder and first evidence suggests that it is also beneficial for patients with FM. Given the complex etiology of FM, a combination of psychotherapy with other treatment options can maximize a potential therapeutic success. A possible candidate herby is transcranial Direct Current Stimulation (tDCS), a non-invasive stimulation technique, which can modify neural activities related to pain and which has shown short-term positive effects on chronic pain and quality of life in FM patients. The patient sample will consist of 96 female patients meeting 2016 American College of Rheumatology criteria for FM based on a clinical interview. They will be randomized to 20 sessions of EMDR plus tDCS or EMDR plus sham-tDCS, or Treatment as Usual (TAU). Therapists, raters, and patients will be kept blind to tDCS treatment conditions. Evaluations will be at baseline, post treatment at 6 months, and follow-up at 12 months. Hypotheses are that EMDR improves pain intensity and clinical symptoms at short and long-term, and that tDCS enhances this effect, which will be superior to tDCS-sham.

Design

Study type: Interventional Phases: Allocation: Randomized Intervention model: Parallel Primary purpose: Treatment Masking/blinding: Quadruple

Interventions / Regimen

  • Behavioral: Eye Movement Desensitization and Reprocessing therapy — EMDR is a psychotherapeutic approach using a standardized 8-phase protocol to alleviate the distress associated with traumatic memories, facilitating the access to and processing of traumatic memories. Patients will receive 20 individual EMDR sessions of 60 minutes each using the standard protocol, as well as a specific pain protocol and the fibromyalgia protocol. EMDR is an integrative psychotherapy that uses standardized protocols and elements of cognitive-behavioral, interpersonal, and body-centered therapies, as well as dual stimulation (e.g., side-to-side eye movements). The current standard protocol includes eight phases: Patient history. Patient preparation. Patient assessment. Memory desensitization. Installing the positive cognition. Body scan. Closure. Reevaluation.
  • Other: transcranial Direct Current Stimulation — tDCS represents a promising intervention option, given its capacity to modulate cerebral excitability in a simple, safe manner. F3 anodal; Fp1, F7, Fc5, AF3, Fc1, Fz, return montage will be used with the anode over the left DLPFC. Half of the patients will receive active stimulation and the other half sham stimulation. Active stimulation will consist of 2mA tDCS for 20 minutes applied immediately before EMDR sessions. The same protocol and montage will be used for sham stimulation.

Primary Outcomes

  • Change in severity and in pain intensity as measured by the Visual Analogue Scale (VAS) (Change from baseline to visits at 6 and 12 months)
  • Change in physical impairment due to FM assessed by The Revised Fibromyalgia Impact Questionnaire (FIQ-R) (Change from baseline to visits at 6 and 12 months)
  • Change in catastrophic thinking related to pain experiences assessed by the Pain Catastrophizing Scale (PCS) (Change from baseline to visits at 6 and 12 months)
  • Change in the impact of fatigue as assessed by the Brief Fatigue Inventory (BFI) (Change from baseline to visits at 6 and 12 months)
  • PTSD diagnosis assessed by the Global Evaluation of Posttraumatic Stress (EGEP-5) (Change from baseline to 6 and 12 months)
  • Complex PTSD diagnosis assessed by The International Trauma Questionnaire (ITQ) (Measure at baseline)
  • Change in PTSD symptoms as measured by the Posttraumatic Stress Disorder Checklist (PCL-5) (Change from baseline to visits at 6 and 12 months)
  • Change in subjective perceived distress assessed by Subjective unit of distress (SUD) (Change from baseline to visits at 6 and 12 months)
Interested in this trial?
Contact the study team directly or view the official listing
Study Information
Type: INTERVENTIONAL
Phase: NA
Status: Recruiting
Start Date: 2025-01-21
Completion: 2026-12-31
Eligibility
Age: 18 Years – 70 Years
Sex: FEMALE
Volunteers: false
Enrollment: 96 (ESTIMATED)
Sponsor & Investigators
Lead Sponsor: Parc de Salut Mar
Collaborators: Universitat Oberta de Catalunya
Principal Investigators:
  • Benedikt L. Amann, M.D. (PRINCIPAL_INVESTIGATOR) - Parc de Salut Mar
Contact Information
Study Contact:
Alicia Valiente Gómez, M.D.
(0034)933268500
avaliente@researchmar.net
Benedikt L. Amann, M.D.
(0034)933268500
62517@parcdesalutmar.cat
Benedikt L. Amann, MD
(0034)933 268 500
62517@parcdesalutmar.cat
Centre Forum (Parc de Salut Mar)
Interventions
  • Behavioral: Eye Movement Desensitization and Reprocessing therapy — EMDR is a psychotherapeutic approach using a standardized 8-phase protocol to alleviate the distress associated with traumatic memories, facilitating the access to and processing of traumatic memories. Patients will receive 20 individual EMDR sessions of 60 minutes each using the standard protocol, as well as a specific pain protocol and the fibromyalgia protocol. EMDR is an integrative psychotherapy that uses standardized protocols and elements of cognitive-behavioral, interpersonal, and body-centered therapies, as well as dual stimulation (e.g., side-to-side eye movements). The current standard protocol includes eight phases: Patient history. Patient preparation. Patient assessment. Memory desensitization. Installing the positive cognition. Body scan. Closure. Reevaluation.
  • Other: transcranial Direct Current Stimulation — tDCS represents a promising intervention option, given its capacity to modulate cerebral excitability in a simple, safe manner. F3 anodal; Fp1, F7, Fc5, AF3, Fc1, Fz, return montage will be used with the anode over the left DLPFC. Half of the patients will receive active stimulation and the other half sham stimulation. Active stimulation will consist of 2mA tDCS for 20 minutes applied immediately before EMDR sessions. The same protocol and montage will be used for sham stimulation.
Study Locations (1 sites)
Centre Forum (Parc de Salut Mar), Barcelona, Catalonia 08019 Spain
Eligibility Criteria
Inclusion Criteria: * Age between 18 and 70 years old * Mean pain score of at least 4 on the visual analog scale (VAS) in the two weeks preceding the clinical trial * Presence of one or more traumatic events causing current trauma-related symptoms * Current clinical symptoms of depression and/or anxiety * 2 weeks of stable medication Exclusion Criteria: * Comorbid autoimmune or chronic inflammatory disease * Neurological or serious medical diseases * Bipolar disorder, schizoaffective disorder and schizophrenia * Suicidal ideation * Previous EMDR therapy in the past two years * Substance abuse/dependency within 1 month prior to participation (except for nicotine abuse/dependency), * Pending FM-related litigation or disability * Metallic implants in the head * Positive test for pregnancy * Skin sensitivity diseases (psoriasis, eczema, dermatitis, etc.)
Conditions Healthy, Major Depressive Disorder (MDD)
Phase Not Applicable
Enrollment 204
Locations 1 sites
Compensation Not reported — ask the study team
Data Updated 2026-11-05
Study Details Design, interventions, and primary outcomes

About This Study

The goal of this observational study is to test whether the discontinuation of antidepressant medications for patients with depression can be decided after the normalization of biological parameters. The main questions it aims are: 1. When patients with depression treated with antidepressants, does their brain activity also become normal? If so, 2. Then, can we stop the antidepressant treatment and expect minimum repeat of depression? The participants who receive a specific antidepressant treatment will be asked to: * Undergo quantitative electroencephalography (qEEG), * Record Event-related potential (ERP), * Record Sleep EEG * Answer Hamilton Depression Rating Scale question their psychiatrists asked * Give blood sample for genetic analysis * Repeat the above mentioned procedures for at least 3 times during their treatment period. Researchers will compare the results of patients with the results of healthy controls.

Design

Study type: Observational Observational model: Case Control Time perspective: Prospective

Interventions / Regimen

  • Drug: Antidepressant Medications — Second generation antidepressants under "selective serotonin reuptake inhibitor" group

Primary Outcomes

  • Relapse rate (From the discontinuation of antidepressant treatment to the first relapse within 6-12 months.)
Interested in this trial?
Contact the study team directly or view the official listing
Study Information
Type: OBSERVATIONAL
Phase: Not Applicable
Status: Recruiting
Start Date: 2025-01-01
Completion: 2027-02-01
Eligibility
Age: 18 Years – 65 Years
Sex: ALL
Volunteers: true
Enrollment: 204 (ESTIMATED)
Sponsor & Investigators
Lead Sponsor: Mehmet Kemal Arikan
Principal Investigators:
  • Mehmet Kemal Arıkan, Prof. (PRINCIPAL_INVESTIGATOR) - Kemal Arikan Psychiatry Clinic
Contact Information
Study Contact:
Mehmet Kemal Arıkan, Prof.
+905325555005
mkarikan46@gmail.com
Reyhan Ilhan, MSc.
05378586677
psy.reyhan.ilhan@gmail.com
Mehmet Kemal Arıkan, Prof. Dr.
+90 532-555-5005
mkarikan46@gmail.com
Prof. Dr. Kemal Arıkan's Psychiatry Clinic
Interventions
  • Drug: Antidepressant Medications — Second generation antidepressants under "selective serotonin reuptake inhibitor" group
Study Locations (1 sites)
Prof. Dr. Kemal Arıkan's Psychiatry Clinic, Istanbul, 34380 Turkey (Türkiye)
Eligibility Criteria
Inclusion Criteria: * Outpatients * For patients, satisfying Major Depressive Disorder for Diagnostic and Statistical Manual of Mental Disorders (DSM-5-TR) * Drug-free for at least 1-week Exclusion Criteria: * Any neurological and psychiatric comorbid conditions * Hearing loss * Physical diseases
Conditions Depression, Anxiety
Phase NA
Enrollment 150
Locations 1 sites
Compensation Not reported — ask the study team
Data Updated 2026-11-05
Study Details Design, interventions, and primary outcomes

About This Study

Mental health is increasingly at the forefront of concerns, especially since the start of COVID-19 pandemic. However, not all individuals under mental subhealth need pharmaceutical treatment. Music Therapy (MT) can make peoples gradually relax via relaxing and soothing music, and regulate individual psychological emotions through the influence of music on individuals' cerebral cortex, hypothalamus and limbic system, further improve the mood of daily tension and anxiety. This study adopted randomized clinical trials design, with two groups of MT group and Waiting group both under mental subhealth. The MT group received music therapy and routine activities, while the Waiting group received music therapy after the therapy of MT group. Data collections were performed by trained, certified, and qualified personnel. The study aims to provide that MT is an effective intervention way to alleviate the mental subhealth state in the future.

Design

Study type: Interventional Phases: Allocation: Randomized Intervention model: Parallel Primary purpose: Treatment Masking/blinding: Triple

Interventions / Regimen

  • Device: The mini apps named "SOUL GYM" on the Wechat — Music Therapy can make peoples gradually relax via relaxing and soothing music, and regulate individual psychological emotions through the influence of music on individuals' cerebral cortex, hypothalamus and limbic system, further improve the mood of daily tension and anxiety.

Primary Outcomes

  • Change from baseline in depressive symptoms assessed by the Patient Health Questionnaire-9 (PHQ-9; range: 0-27) at week 4. (Baseline and week 4.)
  • Change from baseline in anxiety symptoms assessed by the Generalized Anxiety Disorder-7 (GAD-7, range: 0-21) at week 4. (Baseline and week 4.)
  • Change from baseline in insomnia symptoms assessed by the Insomnia Severity Index (ISI; range: 0-28) at week 4. (Baseline and week 4.)
  • Change from baseline in perceived stress assessed by the Perceived Stress Scale-14 (PSS-14; range: 0-56) at week 4. (Baseline and week 4.)
Interested in this trial?
Contact the study team directly or view the official listing
Study Information
Type: INTERVENTIONAL
Phase: NA
Status: Recruiting
Start Date: 2023-04-19
Completion: 2027-10-31
Eligibility
Age: 16 Years – 35 Years
Sex: ALL
Volunteers: true
Enrollment: 150 (ESTIMATED)
Sponsor & Investigators
Lead Sponsor: Jiangsu Province Nanjing Brain Hospital
Principal Investigators:
  • Fei Wang (STUDY_CHAIR) - Affiliated Nanjing Brain Hospital, Nanjing Medical University
Contact Information
Study Contact:
Yue Zhu
02418640297059
zhuyuemiiu@163.com
Fei Wang
86-025-83295957
fei.wang@yale.edu
Affiliated Nanjing Brain Hospital, Nanjing Medical University
Yue Zhu
86-18640297059
zhuyuemiiu@163.com
Affiliated Nanjing Brain Hospital, Nanjing Medical University
Interventions
  • Device: The mini apps named "SOUL GYM" on the Wechat — Music Therapy can make peoples gradually relax via relaxing and soothing music, and regulate individual psychological emotions through the influence of music on individuals' cerebral cortex, hypothalamus and limbic system, further improve the mood of daily tension and anxiety.
Study Locations (1 sites)
Affiliated Nanjing Brain Hospital, Nanjing Medical University, Nanjing, Jiangsu 210000 China
Eligibility Criteria
Inclusion Criteria: A total of \> 5 on PHQ-9 or a total of \> 5 on GAD-7 Exclusion Criteria: Acute suicidal thoughts, With a severe or potentially confounding psychiatric disorder (e.g. psychosis, substance misuse).
Conditions Surgical Stress Response, Stress Physiol...
Phase NA
Enrollment 32
Locations 1 sites
Compensation Not reported — ask the study team
Data Updated 2026-11-05
Study Details Design, interventions, and primary outcomes

About This Study

Postoperative complications after surgical procedures, including following total knee arthroplasty (TKA), have a negative impact on the health and well-being of surgical patients. Older adults (≥65 years) are particularly vulnerable to postoperative complications and their associated morbidities due to the biological aging process. Older adults comprise nearly half of surgical patients worldwide, and this number is expected to increase in the next 10-20 years as the aging population continues to grow. TKA is the most common procedure undergone by older adults, and the rate of TKA procedures is also expected to rise. Despite perioperative guidelines and protocols to prevent postoperative complications, the prevalence of postoperative complications following TKA is approximately 12%. Given these statistics, millions of older adults undergoing TKA may be at risk for postoperative complications and their associated morbidities in the coming decades. Therefore, additional interventions are needed to combat postoperative complications in this population. The body's natural response to surgery, also known as the surgical stress response (SSR), contributes to postoperative complications through complex mechanisms involving the autonomic nervous system (ANS). Increased sympathetic nervous system (SNS) activity, or the body's fight-or-flight response, causes dysregulation in feedback systems that regulate the stress response, potentially leading to poorer outcomes. Interventions, such as breathwork, that induce the parasympathetic nervous system (PNS), or the body's rest-and-digest response, have been shown to balance the ANS, regulate stress biology, and improve outcomes. This study will examine the feasibility of adding a breathwork intervention (Box Breathing), compared to an attention control, to standard perioperative care for older adults undergoing TKA. This study will also examine the proof of concept that Box Breathing, compared to an attention control, may help regulate the SSR by assessing an objective measure of stress-related biology, diurnal cortisol rhythm, and gathering self-report information on pain, anxiety, depression, and quality of recovery following TKA.

Design

Study type: Interventional Phases: Allocation: Randomized Intervention model: Parallel Primary purpose: Basic Science Masking/blinding: Double

Interventions / Regimen

  • Behavioral: A 5-minute Asynchronous Breathwork Intervention — Participants will be guided through the Box Breathing intervention with a pre-recorded YouTube video created by the PI. The video will be embedded into REDCap and delivered online asynchronously to provide flexibility and will be the same for all six sessions. The video will consist of a simple box pattern displayed on the screen with movement around the box that coincides with the PI's voiceover recording of the Box Breathing sequence. . Each session will be five minutes in length, with each section (e.g., inhalation, exhalation, breath retention) of the exercise lasting approximately four seconds. The sequence of each Box Breathing session is performed by breathing through the nose as follows: inhale for 4 seconds, hold the inhalation (lungs "full") for 4 seconds, exhale for 4 seconds, hold the exhalation (lungs "empty") for 4 seconds, and then return to inhaling for 4 seconds. Participants will be encouraged to exhale through the mouth if exhaling through the nose is not accessible.
  • Behavioral: A 5-minute Asynchronous Card Game Video — Participants will watch the TriPeaks video, a pre-recorded YouTube video created by the PI. The video will be embedded into REDCap and delivered online asynchronously to provide flexibility and will be the same for all six sessions. The video will consist of a screen recording of the PI playing the card game TriPeaks. Each session will be five minutes in length to match the Box Breathing intervention dosage and delivery.

Primary Outcomes

  • Study Feasibility via Recruitment (Through study completion, an average of 4.5 months)
  • Study Feasibility via Retention (Through study completion, an average of 4.5 months)
  • Study Feasibility via Receipt of Saliva Samples (Through study completion, an average of 4.5 months)
  • Study Feasibility via Postoperative Morbidity Survey Completion (Through study completion, an average of 4.5 months)
  • Box Breathing Intervention Feasibility via Box Breathing Completion Survey (Through study completion, an average of 4.5 months)
  • Box Breathing Intervention Feasibility via Feasibility of Intervention Measure (FIM) (Measured one time on the evening of Postoperative Day 3)
  • Box Breathing Intervention Acceptability via Acceptability of Intervention Measure (AIM) (Measured one time on the evening of Postoperative Day 3)
  • Box Breathing Intervention Appropriateness via Intervention Appropriateness Measure (IAM) (Measured one time on the evening of Postoperative Day 3)
Interested in this trial?
Contact the study team directly or view the official listing
Study Information
Type: INTERVENTIONAL
Phase: NA
Status: Recruiting
Start Date: 2026-07-01
Completion: 2026-11-30
Eligibility
Age: 65 Years and older
Sex: ALL
Volunteers: true
Enrollment: 32 (ESTIMATED)
Sponsor & Investigators
Lead Sponsor: University of Arizona
Principal Investigators:
  • Devon E Cobos Garcia, PhD Candidate (PRINCIPAL_INVESTIGATOR) - University of Arizona
  • Ruth E Taylor-Piliae, PhD (STUDY_CHAIR) - University of Arizona
  • Thaddeus W W Pace, PhD (STUDY_CHAIR) - University of Arizona
Contact Information
Study Contact:
Devon E Cobos Garcia, PhD Candidate, MS, BSN
904-477-7960
decg0131@arizona.edu
Devon E Cobos Garcia
904-477-7960
decg0131@arizona.edu
The University of Arizona
Interventions
  • Behavioral: A 5-minute Asynchronous Breathwork Intervention — Participants will be guided through the Box Breathing intervention with a pre-recorded YouTube video created by the PI. The video will be embedded into REDCap and delivered online asynchronously to provide flexibility and will be the same for all six sessions. The video will consist of a simple box pattern displayed on the screen with movement around the box that coincides with the PI's voiceover recording of the Box Breathing sequence. . Each session will be five minutes in length, with each section (e.g., inhalation, exhalation, breath retention) of the exercise lasting approximately four seconds. The sequence of each Box Breathing session is performed by breathing through the nose as follows: inhale for 4 seconds, hold the inhalation (lungs "full") for 4 seconds, exhale for 4 seconds, hold the exhalation (lungs "empty") for 4 seconds, and then return to inhaling for 4 seconds. Participants will be encouraged to exhale through the mouth if exhaling through the nose is not accessible.
  • Behavioral: A 5-minute Asynchronous Card Game Video — Participants will watch the TriPeaks video, a pre-recorded YouTube video created by the PI. The video will be embedded into REDCap and delivered online asynchronously to provide flexibility and will be the same for all six sessions. The video will consist of a screen recording of the PI playing the card game TriPeaks. Each session will be five minutes in length to match the Box Breathing intervention dosage and delivery.
Study Locations (1 sites)
The University of Arizona, Tucson, Arizona 85721 United States
Eligibility Criteria
Adults aged 65 years or older of any sex, gender and ethnic background who meet the following criteria will be eligible to enroll in the present study: Inclusion Criteria: * scheduled for elective TKA within the next week to two months (can be second knee, but cannot be a revision of the original knee) * self-reported good health, including denial of debilitating illness that may affect participation in or be potentially exacerbated by deep, controlled breathing (i.e., chronic obstructive pulmonary disorder \[COPD\], symptomatic or advanced heart failure, complete heart block, glaucoma, epilepsy) * denial of conditions that alter cortisol release or that require corticosteroid therapy (i.e., Cushing's syndrome, Addison's disease, pituitary tumors, adrenal gland tumors, asthma) * denial of severe psychiatric or cognitive conditions that warrant the need for a durable power of attorney (DPOA) * able to understand written and verbal English. Exclusion Criteria: * currently taking oral, injectable, intranasal, topical, or inhaled corticosteroid medications (i.e., prednisone, hydrocortisone, dexamethasone, methylprednisolone, methylprednisolone acetate, triamcinolone, betamethasone, mometasone, fluticasone, budesonide, clobetasol) * do not have the technology requirements to complete data collection (i.e., participant does not have a smartphone, tablet, laptop, or desktop computer; lack of reliable internet) The following exclusion criteria may affect participants' ability to remain in the study following enrollment: • Development of complications during surgery that require prolonged hospitalization into Postoperative Day (POD) 2 (e.g., postoperative intubation and ventilation requirements, intractable pain, intractable nausea/vomiting, signs of infection or sepsis)
Conditions Depression, Cognitive Decline
Phase NA
Enrollment 300
Locations 2 sites
Compensation Not reported — ask the study team
Data Updated 2026-11-05
Study Details Design, interventions, and primary outcomes

About This Study

Depression affects one-third of intensive care unit (ICU) survivors and represents a potentially modifiable target to slow cognitive decline and reduce the risk of Alzheimer's disease and related dementias (ADRD). Our multi-PI team proposes a two-arm RCT called ADEPT-ICU (Attenuating DEPression with Internet CBT to Slow Cognitive Decline in Older ICU Survivors), which will test the efficacy of an internet CBT intervention called Good Days Ahead (GDA) to reduce the burden of subjective cognitive decline (SCD) in older ICU survivors with moderate to severe depressive symptoms after ICU hospitalization.

Design

Study type: Interventional Phases: Allocation: Randomized Intervention model: Parallel Primary purpose: Treatment Masking/blinding: Double

Interventions / Regimen

  • Behavioral: Therapist-Assisted Internet Cognitive-Behavioral Therapy for Depression — Good Days Ahead (MindStreet, Inc.)
  • Behavioral: Active Control — Depression education, symptom monitoring, and standard depression care

Primary Outcomes

  • Subjective Cognitive Decline (Measured at 6-month and 12-month follow-up.)
Interested in this trial?
Contact the study team directly or view the official listing
Study Information
Type: INTERVENTIONAL
Phase: NA
Status: Recruiting
Start Date: 2025-03-13
Completion: 2029-10-30
Eligibility
Age: 50 Years and older
Sex: ALL
Volunteers: false
Enrollment: 300 (ESTIMATED)
Sponsor & Investigators
Lead Sponsor: Indiana University
Collaborators: National Institute on Aging (NIA)
Principal Investigators:
  • Babar Khan, MD, MS (PRINCIPAL_INVESTIGATOR) - Indiana University
Contact Information
Study Contact:
Babar Khan, MD, MS
317-274-9132
bakhan@iu.edu
Lori Rawlings, RN, BSN
317-274-9052
rawlingl@regenstrief.org
Babar Khan, MD, MS
317-274-9132
bakhan@iu.edu
Eskenazi Hospital
Interventions
  • Behavioral: Therapist-Assisted Internet Cognitive-Behavioral Therapy for Depression — Good Days Ahead (MindStreet, Inc.)
  • Behavioral: Active Control — Depression education, symptom monitoring, and standard depression care
Study Locations (2 sites)
Eskenazi Hospital, Indianapolis, Indiana 46202 United States
IU Health Methodist Hospital, Indianapolis, Indiana 46202 United States
Eligibility Criteria
Inclusion Criteria 1. 50 years of age and older 2. Admitted to the intensive care for greater \> 48 hours 3. Able to understand and provide informed consent 4. Elevated depressive symptoms, defined as Screening PHQ-9 or PHQ-8 ≥ 10 or Screening PHQ-9 or PHQ-8 = 5-9 with the presence a core symptom of anhedonia (PHQ-9 or PHQ-8 Item 1) or depressed mood (PHQ-9 or PHQ-8 Item 2) 5. Willing to participate in cognitive testing 6. Access to a telephone 7. Discharge to home or an independent or assisted living facility 8. Response is a 1,2, or 3 on PHQ-9 or PHQ-8 item 7, answered yes to "Have you experienced a change in your memory or other aspect of thinking in the past 1 to 3 years?", or score in the 25% percentile or lower on the Montreal Cognitive Assessment (MOCA) based on normative data which account for age, gender, race, ethnicity and education. Exclusion Criteria: 1. Diagnosis of dementia or neurodegenerative disease (e.g. Alzheimer's disease, vascular dementia as per EHR and IQCODE, or Parkinson's disease) or on anti-dementia medications prior to ICU stay 2. Diagnosis of severe mental illness (bipolar disorder, schizophrenia, schizoaffective) as per EHR and screening questions 3. Persistent psychotic symptoms after ICU stay which would interfere with successful completion of intervention 4. Recent or recurrent alcohol or substance use disorder as per HER and Drug Abuse Screening Test 5. Life expectancy less than 1 year (e.g. terminal cancer diagnosis, discharged on hospice) 6. Ischemic or hemorrhagic stroke, traumatic brain injury, or undergoing neurosurgery prior, during or after ICU stay 7. Uncorrected visual or auditory impairment including legal blindness or deaf 8. Status post tracheostomy and not able to communicate 9. Incarcerated or on parole after ICU stay
Conditions Anhedonia, Anxiety, Stress, Depression
Phase NA
Enrollment 60
Locations 1 sites
Compensation Not reported — ask the study team
Data Updated 2026-11-05
Study Details Design, interventions, and primary outcomes

About This Study

The present study evaluates a two week ecological momentary intervention (EMI) in reducing anhedonia and psychological distress (i.e. elevated depression, stress and anxiety). Participants in the experimental group complete three daily exercises targeting reward-related processes, including positive mental imagery, savoring, gratitude, taking ownership for positive experience, and silver lining. These components were selected to improve reward anticipation as well as reward consumption and reward learning as the underlying mechanisms of anhedonia. An active control group receives progressive muscle relaxation training, matched in format and frequency. Exercise units are presented using audio recordings via smartphone app.

Design

Study type: Interventional Phases: Allocation: Randomized Intervention model: Parallel Primary purpose: Treatment Masking/blinding: Single

Interventions / Regimen

  • Behavioral: Training of reward processing/sensitivity — Participants in the experimental group complete a two-week ecological momentary intervention (EMI) consisting of three brief training units per day, each delivered via a smartphone. The exercises target different aspects of reward processing and are scheduled at specific times throughout the day. The morning unit (to be completed between 10:00 and 12:00 a.m.) involves a positive mental imagery task guided by audio recording. Participants are guided to vividly imagine a future situation with the most pleasurable and meaningful outcome possible. They are encouraged to mentally activate all senses, thoughts, and emotions associated with this scenario. The afternoon unit (to be completed between 3:00 and 5:00 p.m.) consists of a savoring exercise guided by audio recording. Participants recall a positive experience from the past and are instructed to re-experience and savor it mentally by focusing on its sensory details, emotional quality, and personal significance. The evening unit (to be
  • Behavioral: Relaxation Training (PMR) — Participants in the control group complete a two-week progressive muscle relaxation (PMR) program designed to match the reward training in both frequency and duration. The intervention consists of three daily units, each delivered via a smartphone app and guided by audio recordings. The first and second units of each day consist of short audio-guided PMR sessions (approximately 5 minutes each). These exercises systematically guide participants through alternating tension and relaxation of different muscle groups to promote physical and mental relaxation. The third unit of the day focuses on reflection. Participants are asked to evaluate their experiences with the relaxation exercises over the course of the day. They reflect on their ability to engage with the exercises, the perceived effects (e.g., feelings of relaxation), any difficulties they encountered, and strategies to enhance the effectiveness of relaxation in their daily life beyond the intervention.
  • Other: Psychoeducation — All participants receive a psychoeducation session on the day before the respective intervention starts. In this session, a graduate-level study team member introduces the rationale behind the training (PMR or reward-training), and demonstrates each exercise. Participants also practice each task.

Primary Outcomes

  • Change in anhedonia/hedonic capacity; measured with the Snaith-Hamilton Pleasure Scale (SHAPS) from baseline to post-intervention and baseline to 3-months follow-up (Baseline, 2 weeks (completion of intervention) and 3 months)
  • Change in depression, anxiety and stress; measured with the Depression-Anxiety-Stress-Scale (DASS-21) from baseline to completion and baseline to follow-up (Baseline, 2 weeks (completion of intervention) and 3 months)
Interested in this trial?
Contact the study team directly or view the official listing
Study Information
Type: INTERVENTIONAL
Phase: NA
Status: Recruiting
Start Date: 2025-06-18
Completion: 2026-01
Eligibility
Age: 18 Years and older
Sex: ALL
Volunteers: false
Enrollment: 60 (ESTIMATED)
Sponsor & Investigators
Lead Sponsor: Philipps University Marburg
Contact Information
Study Contact:
Martin J Skopp, M.Sc.
+4964212827106
martin.skopp@uni-marburg.de
Martin J Skopp, M.Sc.
+4964212827106
martin.skopp@uni-marburg.de
Philipps-University Marburg
Interventions
  • Behavioral: Training of reward processing/sensitivity — Participants in the experimental group complete a two-week ecological momentary intervention (EMI) consisting of three brief training units per day, each delivered via a smartphone. The exercises target different aspects of reward processing and are scheduled at specific times throughout the day. The morning unit (to be completed between 10:00 and 12:00 a.m.) involves a positive mental imagery task guided by audio recording. Participants are guided to vividly imagine a future situation with the most pleasurable and meaningful outcome possible. They are encouraged to mentally activate all senses, thoughts, and emotions associated with this scenario. The afternoon unit (to be completed between 3:00 and 5:00 p.m.) consists of a savoring exercise guided by audio recording. Participants recall a positive experience from the past and are instructed to re-experience and savor it mentally by focusing on its sensory details, emotional quality, and personal significance. The evening unit (to be
  • Behavioral: Relaxation Training (PMR) — Participants in the control group complete a two-week progressive muscle relaxation (PMR) program designed to match the reward training in both frequency and duration. The intervention consists of three daily units, each delivered via a smartphone app and guided by audio recordings. The first and second units of each day consist of short audio-guided PMR sessions (approximately 5 minutes each). These exercises systematically guide participants through alternating tension and relaxation of different muscle groups to promote physical and mental relaxation. The third unit of the day focuses on reflection. Participants are asked to evaluate their experiences with the relaxation exercises over the course of the day. They reflect on their ability to engage with the exercises, the perceived effects (e.g., feelings of relaxation), any difficulties they encountered, and strategies to enhance the effectiveness of relaxation in their daily life beyond the intervention.
  • Other: Psychoeducation — All participants receive a psychoeducation session on the day before the respective intervention starts. In this session, a graduate-level study team member introduces the rationale behind the training (PMR or reward-training), and demonstrates each exercise. Participants also practice each task.
Study Locations (1 sites)
Philipps-University Marburg, Marburg, Hesse 35037 Germany
Eligibility Criteria
Inclusion Criteria: * German speaking * Smartphone available and willingness to participate in repeated training units and questions delivered via app * Clinically elevated anhedonia (SHAPS \>= 25) and elevated depression (DASS-21-Depression \>= 10), elevated anxiey (DASS-21-Anxiety \>= 6) or elevated stress (DASS-21-Stress \>= 10) Exclusion Criteria: * Psychotropic medication * Psychotherapy currently ongoing or planned during participation * Suicidality, lifetime diagnosis of bipolar disorders or psychotic episodes